AVADEL PHARMACEUTICALS PLC (AVDL)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AVADEL PHARMACEUTICALS PLC chart...

About the Company

Avadel Pharmaceuticals plc, is a specialty pharmaceutical company. Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. The company was founded as Flamel Technologies SA in Lyon, France in 1990. The company acquired Éclat Pharmaceuticals of St. Louis, Missouri in March 2012. On 8 February 2016, the company acquired FSC Holdings, LLC, which included its wholly owned subsidiaries FSC Pediatrics, Inc., FSC Therapeutics, LLC, and FSC Laboratories, Inc. On 3 January 2017, Flamel, Éclat, and FCS Pediatrics became Avadel Pharmaceuticals plc after the Company completed a cross-border merger from France to Ireland. In 2019, Mike Anderson, CEO of Avadel Pharmaceuticals has resigned, and Gregory Divis, COO of the company was appointed as his temporary successor. Meanwhile, Craig Stapleton, chairman of the Dublin-headquartered Avadel, has also stepped down. That same year, the company filed for Chapter 11 bankruptcy. In May 2023, Avadel Pharmaceuticals received FDA approval for Lumryz, an extended-release oral suspension of sodium oxybate.

Exchange

Nasdaq

$M

Total Revenue

None

Employees

$2B

Market Capitalization

-8.56

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AVDL News

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

14d ago, source:

Avadel Pharmaceuticals plc (NASDAQ:AVDL) is possibly approaching a major achievement in its business, so we would like to ...

Avadel Pharmaceuticals plc (AVDL)

1d ago, source: Yahoo Finance

DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today ...

Avadel Pharmaceuticals PLC ADR

2d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Real-Time Update: Avadel Pharmaceuticals plc (AVDL) Stock Navigates the Market with Up-to-Date Data

8d ago, source: newsheater

To put it simply, Avadel Pharmaceuticals plc (AVDL) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”.

Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Issues Statement On Patent Litigation

1mon ago, source: Finanznachrichten

DUBLIN, Ireland, March 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today issued a statement in response to a jury ruling from the United States District Court for the ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

1mon ago, source: Insider Monkey

Matt Kaplan: Sounds good. Thanks a lot. Gregory Divis: Thanks, Matt. Operator: One moment for the next question. The next question comes from Oren Livnat with H.C. Wainwright. Your line is open ...

Avadel Pharmaceuticals Provides Corporate Update

1mon ago, source: ADVFN

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the steps it is taking to explore every available ...

AVDL Avadel Pharmaceuticals plc

2d ago, source: Seeking Alpha

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial ...

Avadel Pharmaceuticals PLC AVDL

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Avadel Pharmaceuticals PLC AVDL

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Avadel Pharmaceuticals plc

6d ago, source: U.S. News & World Report

For most investors, the best investment strategy is to buy good stocks and hold them for the long run.

Avadel Pharmaceuticals PLC

19d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...